Lei Wang

Dr. Lei Wang


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 February 2017 in Journal of Translational Medicine
Verified
Journal Article
Open access
PDF file
YYYushi Yao
Yushi Yao
LWLei Wang
Lei Wang
JZJihao Zhou
Jihao Zhou
XZXinyou Zhang
Xinyou Zhang
Acute graft-versus-host disease (aGVHD) remains a major obstacle against favorable clinical outcomes following allogeneic hematopoietic stem cell transplantation (allo-HSCT). T helper cells including Th17 play key roles in aGVHD pathogenesis. Donor regulatory T cell (Tregs) adoptive therapy reduces aGVHD without weakening graft-versus-leukemia effect (GVL) in both mouse and human, although the purification and ex vivo expansion of Tregs in clinical scenarios remain costly and technically demanding. Hypoxia-inducible factor 1 alpha (HIF-1α) is a key molecule switch that attenuates Treg but promotes Th17 development. However, whether pharmacological inhibition of HIF-1α reduces aGVHD via increasing Treg development and diminishing Th17 responses remains unexplored. By using alloantigen-specific mixed lymphocyte culture and murine models of aGVHD and GVL, we evaluated the impacts of HIF-1α inhibition by echinomycin on the alloantigen-specific CD4 T cell responses ex vivo, as well as on aGVHD and GVL effect following allo-HSCT. Ex vivo echinomycin treatment resulted in increased number of Tregs in the culture as well as reduced alloantigen-specific Th17 and Th1 responses. In vivo echinomycin treatment reduced GVHD scores and prolonged survival of mice following allo-HSCT, which is associated with increased number of donor Tregs and reduced number of Th17 and Th1 in lymphoid tissues. In murine model of leukemia, echinomycin treatment preserved GVL effect and prolonged leukemia free survival following allo-HSCT. Echinomycin treatment reduces aGVHD and preserves GVL effect via increasing donor Treg development and diminishing alloantigen-specific Th17 and Th1 responses following allo-HSCT, presumably via direct inhibition of HIF-1α that results in preferential Treg differentiation during alloantigen-specific CD4 T cell responses. These findings highlight pharmacological inhibition of HIF-1α as a promising strategy in GVHD prophylaxis.

1 December 2021 in Clinical Nutrition ESPEN
Verified
Journal Article
Closed access
HLHui Li
Hui Li
SXShengzhi Xie
Shengzhi Xie
XZXuyi Zhang
Xuyi Zhang
YXYixin Xia
Yixin Xia
YZYun Zhang
Yun Zhang
LWLei Wang
Lei Wang

25 May 2025 in bioRxiv
Verified
Preprint
Open access
PDF file
YWYanling Wang
Yanling Wang
JZJinjing Zhang
Jinjing Zhang
YLYing Li
Ying Li
TWTao Wang
Tao Wang
LWLu Wang
Lu Wang
YYYushi Yao
Yushi Yao
Neutrophils adapt to tissue-specific signals and exert innate defense functions against infections and malignancies. Fat-rich diet (FRD), such as high-fat diet (HFD) and ketogenic diet (KD), has complex impacts on immunity. However, whether and how FRD shapes tissue-specific functions of neutrophils remain unclear. Here we show that both isocaloric HFD- and KD-fed mice demonstrate enhanced neutrophil-mediated pulmonary tumor resistance than chow diet-fed mice. Intrapulmonary but not systemic neutrophils in FRD-fed mice bear enhanced potential of reactive oxygen species (ROS) production and ROS-dependent tumor cytotoxicity. Mechanistically, FRD-induced increased serum saturated fatty acids and cholesterol stimulate lung vascular endothelial cells (LVECs), which reprogram intrapulmonary neutrophils via contact- and intercellular adhesion molecule-1 (ICAM-1)-dependent mechanisms. Analysis on human lung single-cell RNA sequencing data showed that intensified cell adhesion and priming signals from human LVECs are associated with enhanced antitumor functions in intrapulmonary neutrophils. Our findings highlight the roles of dietary fats in shaping neutrophil functions in a tissue-specific manner. Dietary intervention targeting tissue-specific reprogramming of neutrophils therefore represents a potential strategy against malignancies in the lungs.